Analyst firms · H.C. Wainwright · OCUL

H.C. Wainwright OCUL price target and rating history

Ocular Therapeutix Inc. (OCUL) · Health Care

H.C. Wainwright rates Ocular Therapeutix Inc. (OCUL) Buy with a $14 price target, as of its latest action on Oct 25, 2021. It has published 3 rating actions on OCUL since August 2021, including 1 upgrade and 0 downgrades.

Current rating
Buy
Price target
$14
Median target, all firms
Too few
Actions on OCUL
3

H.C. Wainwright price target on OCUL

$18$16$1420222023202420252026
H.C. Wainwright price target on OCUL, each point a stated target, August 2021 to October 2021.

Every H.C. Wainwright rating on OCUL

Questions about H.C. Wainwright and OCUL

What is H.C. Wainwright's price target for OCUL?
H.C. Wainwright's latest stated price target for Ocular Therapeutix Inc. (OCUL) is $14, from its action on Oct 25, 2021.
What is H.C. Wainwright's rating on OCUL?
H.C. Wainwright rates OCUL Buy, a bullish rating, as of Oct 25, 2021.
When did H.C. Wainwright last change its view on OCUL?
On Oct 25, 2021, H.C. Wainwright cuts its price target to $14 from $18, keeps Buy.

More OCUL rating histories

All H.C. Wainwright ratingsOCUL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.